APA

Burger D. M., van Rossum A. M., Hugen P. W., Suur M. H., Hartwig N. G., Geelen S. P., Scherpbier H. J., Hoetelmans R. M., Vulto A. G. & de Groot R. (20010510). Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children. : Antimicrobial agents and chemotherapy.

Chicago

Burger D M, van Rossum A M, Hugen P W, Suur M H, Hartwig N G, Geelen S P, Scherpbier H J, Hoetelmans R M, Vulto A G and de Groot R. 20010510. Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children. : Antimicrobial agents and chemotherapy.

Harvard

Burger D. M., van Rossum A. M., Hugen P. W., Suur M. H., Hartwig N. G., Geelen S. P., Scherpbier H. J., Hoetelmans R. M., Vulto A. G. and de Groot R. (20010510). Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children. : Antimicrobial agents and chemotherapy.

MLA

Burger D M, van Rossum A M, Hugen P W, Suur M H, Hartwig N G, Geelen S P, Scherpbier H J, Hoetelmans R M, Vulto A G and de Groot R. Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children. : Antimicrobial agents and chemotherapy. 20010510.